Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

INTRODUCTION: Anti-tumour necrosis factor (TNF) therapy is a mainstay of treatment in rheumatoid arthritis (RA). In 2001, BSRBR was established to evaluate the safety of these agents. This paper addresses the safety of anti-TNF therapy in RA with specific reference to serious skin and soft tissue in...

Descripción completa

Detalles Bibliográficos
Autores principales: Galloway, James B, Mercer, Louise K, Moseley, Alison, Dixon, William G, Ustianowski, Andrew P, Helbert, Matthew, Watson, Kath D, Lunt, Mark, Hyrich, Kimme L, Symmons, Deborah PM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595979/
https://www.ncbi.nlm.nih.gov/pubmed/22532633
http://dx.doi.org/10.1136/annrheumdis-2011-201108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595979/
https://www.ncbi.nlm.nih.gov/pubmed/22532633
http://dx.doi.org/10.1136/annrheumdis-2011-201108

Ejemplares similares